Evaxion Biotech Appoints Marianne Søgaard as Chairwoman

0
111

COPENHAGEN, Denmark, Dec. 17, 2020 (GLOBE NEWSWIRE) — Evaxion Biotech A/S, a clinical-stage biotechnology company developing AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced today the appointment of previously practicing commercial, technology and corporate lawyer Marianne Søgaard as Chairwoman of the Board of Directors.

Marianne Søgaard has been an executive and most recently Senior Vice President and General Counsel at Evaxion since 2018. Prior to that, she served for 22 years as lawyer and partner of the law firm Poul Schmith where she primarily focused on acquisitions of processes and technology solutions. She was also a member of the Board of Directors of Poul Schmith from 2014 to 2017. Currently, Mrs. Søgaard serves on a number of Boards of …

Full story available on Benzinga.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here